Esketamine or ketamine or (s)-ketamine

This classification denotes an anesthetic agent with the molecular formula C13H16ClNO, a preparation that US FDA recognizes as an active ingredient or moiety under Unique Ingredient Identifier 690G0D6V8H, chemically known as cyclohexanone, 2-(o-chlorophenyl)-2-(methylamino)-, (+/-)- (8ci) but more generally known as ketamine, which bears U.S. National Institutes of Health Compound Identifier 3821. The European Medicines Agency schedules Ketamine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08365MIG. The term KETAMINE is an International Non-Proprietary Name or INN (see World Health Organization INN reference publication, Volume 6, No, 3 1992, List 32). The World Health Organization schedules ketamine in its Anatomical Therapeutic Chemical (ATC) Classification. KETAMINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. SMILES: CLC1C(C2(NC)CCCCC2=O)CCCC1.